Literature DB >> 28301272

Speech recognition in bilaterally cochlear implanted adults in Tokyo, Japan.

Yoko Ohta1, Atsushi Kawano1, Sachie Kawaguchi1, Kyoko Shirai1, Kiyoaki Tsukahara1.   

Abstract

INTRODUCTION: The clinical effects of bilateral cochlear implantation (BCI) include binaural summation and better hearing under noise conditions. This study retrospectively examined the utility of BCI compared to unilateral cochlear implantation (CI) in adults. PATIENTS AND METHODS: We investigated 34 adults who underwent BCI, comparing speech recognition between BCI and first CI under silent and noise conditions. We assessed correlations between speech recognition after first and second CIs, and between the interval from first to second CI surgery and speech recognition of second CI.
RESULTS: Word recognition score (WRS) and sentence recognition score (SRS) were significantly better after BCI than after first CI under conditions of silence and noise. No significant correlation was found between speech recognition after first CI and that after second CI, or between inter-implant interval and speech recognition of second CI for either WRS or SRS.
CONCLUSIONS: The utility of BCI in Japanese patients was shown. Patients have no need to be pessimistic about hearing after the second implantation even if speech recognition after the first implantation is poor. A long interval from first CI does not necessarily contraindicate contralateral implantation in adults.

Entities:  

Keywords:  Bilateral; adult; cochlear implant; inter-implant interval; speech recognition

Mesh:

Year:  2017        PMID: 28301272     DOI: 10.1080/00016489.2017.1293293

Source DB:  PubMed          Journal:  Acta Otolaryngol        ISSN: 0001-6489            Impact factor:   1.494


  1 in total

1.  Cochlear implantation in a patient with a POU4F3 mutation.

Authors:  Keitaro Miyake; Kyoko Shirai; Nobuhiro Nishiyama; Sachie Kawaguchi; Yoko Ohta; Atsushi Kawano; Shin-Ichi Usami; Tomohiro Kitano; Kiyoaki Tsukahara
Journal:  Clin Case Rep       Date:  2020-11-11
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.